{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:22:28Z","timestamp":1783056148385,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.nucmedbio.2007.04.002","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T09:04:40Z","timestamp":1181552680000},"page":"503-510","source":"Crossref","is-referenced-by-count":28,"title":["Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors"],"prefix":"10.1016","volume":"34","author":[{"given":"Hirofumi","family":"Hanaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Habashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2007.04.002_bib1","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib3","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","article-title":"Matrix metalloproteinases: biologic activity and clinical implications","volume":"18","author":"Nelson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03032599","article-title":"The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis","volume":"7","author":"John","year":"2001","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/cncr.10355","article-title":"Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion","volume":"94","author":"Di Nezza","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00432-001-0320-3","article-title":"Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis","volume":"128","author":"Hrabec","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.bjc.6600366","article-title":"Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer","volume":"86","author":"Waas","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","article-title":"Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura","volume":"88","author":"Edwards","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"93","author":"Hidalgo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib12","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/11703","article-title":"Tumor targeting with a selective gelatinase inhibitor","volume":"17","author":"Koivunen","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/med.20002","article-title":"Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases","volume":"24","author":"Okarvi","year":"2004","journal-title":"Med Res Rev"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1097-0215(20000820)90:4<186::AID-IJC2>3.0.CO;2-P","article-title":"Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy","volume":"90","author":"van Hagen","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0969-8051(01)00241-4","article-title":"Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides","volume":"28","author":"Akizawa","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1248\/bpb.27.271","article-title":"Effect of carboxylation of N-terminal phenylalanine of 111In-DTPA (diethylenetriaminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney","volume":"27","author":"Akizawa","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib19","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/jm950949+","article-title":"Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative","volume":"39","author":"Arano","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib20","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/jm00042a014","article-title":"Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization","volume":"37","author":"Arano","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/bc970023b","article-title":"Conventional and high-yield synthesis of DTPA-conjugated peptides: application of a monoreactive DTPA to DTPA-d-Phe1-octreotide synthesis","volume":"8","author":"Arano","year":"1997","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib22","first-page":"900","article-title":"Characterization of the two diastereomers of octreoscan-111, an In-111 labeled peptide for use in cancer imaging","volume":"33","author":"Albert","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0969-8051(01)00207-4","article-title":"Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides","volume":"28","author":"Akizawa","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib24","first-page":"5539","article-title":"Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells","volume":"48","author":"Schultz","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jnci\/82.7.589","article-title":"Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases","volume":"82","author":"Alvarez","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1021\/bc010028f","article-title":"Synthesis and characterization of 111In-DTPA-N-TIMP-2: a radiopharmaceutical for imaging matrix metalloproteinase expression","volume":"12","author":"Giersing","year":"2001","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s002590100522","article-title":"In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection","volume":"28","author":"Kulasegaram","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jlcr.616","article-title":"Design and synthesis of fluorine-18 labeled matrix metalloproteinase inhibitor for cancer imaging","volume":"45","author":"Furumoto","year":"2002","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0969-8051(02)00338-4","article-title":"Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents","volume":"29","author":"Zheng","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0969-8051(02)00393-1","article-title":"Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor","volume":"30","author":"Furumoto","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0969-8051(03)00086-6","article-title":"Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester","volume":"30","author":"Zheng","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jlcr.695","article-title":"Carbon-11 labelling of an N-sulfonylamino acid derivative: a potential tracer for MMP-2 and MMP-9 imaging","volume":"46","author":"Kuhnast","year":"2003","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0969-8051(03)00111-2","article-title":"Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2- (4\u2032-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4\u2032-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide","volume":"31","author":"Zheng","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib34","first-page":"201","article-title":"Imaging matrix metalloproteinase expression in tumors","volume":"47","author":"Li","year":"2003","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nucmedbio.2003.10.011","article-title":"Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide","volume":"31","author":"Kuhnast","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib36","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family","volume":"87","author":"Van","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2007.04.002_bib37","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.284.5420.1667","article-title":"Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed","volume":"284","author":"Morgunova","year":"1999","journal-title":"Science"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T20:55:37Z","timestamp":1556484937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805107000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0969805107000972"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.04.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}